Close Menu

NEW YORK (GenomeWeb) – Guardant Health said after the close of the market Monday that it has commenced a public offering of up to 4.5 million shares of its common stock. In addition, the company expects to grant underwriters a 30-day option to purchase an additional 675,000 shares.

JP Morgan Securities and BofA Merrill Lynch are serving as joint lead book-running managers. A registration statement related to the securities has been filed with the SEC but is not yet effective.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.